Revision history of "Development of therapeutic IgA molecules and expression platform for SARS-CoV" (Q3069477)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

9 October 2024

  • curprev 09:3109:31, 9 October 2024DG Regio talk contribs 45,894 bytes +2 Changed label, description and/or aliases in pt
  • curprev 09:3109:31, 9 October 2024DG Regio talk contribs 45,892 bytes +7 Set a claim value: summary (P836): O objetivo do projeto é desenvolver uma plataforma de desenvolvimento de candidatos a anticorpos antivirais para medicamentos. O projeto desenvolverá tecnologias para o desenvolvimento e a produção de anticorpos com base na imunoglobulina secretora A. A fim de validar a nova abordagem, devem ser realizados ensaios em animais em anticorpos contra o SARS-CoV-2 desenvolvidos pelo requerente, conduzindo ao isótipo de anticorpos da imunoglobulina secreto...

7 March 2024

6 November 2023

20 June 2023

12 June 2023

17 August 2022

  • curprev 14:3714:37, 17 August 2022DG Regio talk contribs 43,770 bytes +26,636 Changed label, description and/or aliases in el, da, fi, mt, lv, sk, ga, cs, pt, hu, bg, lt, hr, sv, ro, sl, pl, nl, et, fr, de, it, es, and other parts: Adding translations: el, da, fi, mt, lv, sk, ga, cs, pt, hu, bg, lt, hr, sv, ro, sl, pl,

13 January 2022

12 January 2022

5 December 2021

30 November 2021

  • curprev 14:2214:22, 30 November 2021DG Regio talk contribs 12,839 bytes +1,288 Created claim: summary (P836): Ziel des Projekts ist die Entwicklung einer Entwicklungsplattform für antivirale Antikörperkandidaten für Arzneimittel. Das Projekt wird Technologien für die Entwicklung und Herstellung von Antikörpern auf Basis von sekretorischem Immunglobulin A entwickeln. Zur Validierung des neuartigen Ansatzes sind Tierversuche an vom Antragsteller entwickelten Antikörpern gegen SARS-CoV-2 durchzuführen, die zu sekretorischem Immunglobulin-A-Antikörperisotyp...
  • curprev 14:2214:22, 30 November 2021DG Regio talk contribs 11,551 bytes +139 Changed label, description and/or aliases in de: translated_label

26 November 2021

  • curprev 06:3006:30, 26 November 2021DG Regio talk contribs 11,412 bytes +1,345 Created claim: summary (P836): L’objectif du projet est de développer une plate-forme de développement pour les candidats aux anticorps antiviraux pour les médicaments. Le projet mettra au point des technologies pour le développement et la production d’anticorps à base d’immunoglobuline A sécrétoire. Afin de valider la nouvelle approche, des essais sur les animaux doivent être effectués sur des anticorps contre le SRAS-CoV-2 mis au point par le demandeur, conduisant à l’isoty...
  • curprev 06:3006:30, 26 November 2021DG Regio talk contribs 10,067 bytes +157 Changed label, description and/or aliases in fr: translated_label

18 August 2021

16 August 2021